Bassler Bonnie L (CIK 1683607) reported 14 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-30). Recent activity: Buy RPRX (689 shares), Buy RPRX (4,545 shares), Buy RPRX (815 shares), Buy REGN (1,500 shares), Sell REGN (1,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Royalty Pharma plc (RPRX) | Director | Buy | 689 | $37,481 |
| 2026-06-08 | Royalty Pharma plc (RPRX) | Director | Buy | 4,545 | $0 |
| 2026-03-31 | Royalty Pharma plc (RPRX) | Director | Buy | 815 | $37,474 |
| 2026-01-08 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Buy | 1,500 | $561,180 |
| 2026-01-08 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 1,500 | $1.2M |
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) | Director | Sell | 15 | $3,322 |
| 2026-01-06 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Buy | 155 | $0 |
| 2026-01-02 | Royalty Pharma plc (RPRX) | Director | Buy | 967 | $37,462 |
| 2025-11-24 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Buy | 760 | $282,264 |
| 2025-11-24 | REGENERON PHARMACEUTICALS, INC. (REGN) | Director | Sell | 760 | $570,000 |
| 2025-09-30 | Royalty Pharma plc (RPRX) | Director | Buy | 1,047 | $37,472 |
| 2025-06-30 | Royalty Pharma plc (RPRX) | Director | Buy | 1,064 | $37,495 |
| 2025-05-14 | Royalty Pharma plc (RPRX) | Director | Buy | 7,614 | $0 |
| 2025-04-01 | Royalty Pharma plc (RPRX) | Director | Buy | 1,141 | $37,505 |
Source: SEC Form 4 filings · as of 2026-06-30